Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-14

Clinical Trial Update: Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing feasibility and safety of giving IV sotalol as a loading dose to start oral sotalol therapy for arrhythmias and atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sotalol (Sotalol)

Snippet

Sponsor: Kansas City Heart Rhythm Research Foundation | Conditions: Arrhythmias, Cardiac, Atrial Fibrillation | Phase 4 | Status: UNKNOWN